Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.

@article{Tefferi2011MyeloproliferativeNM,
  title={Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.},
  author={Ayalew Tefferi and William Vainchenker},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2011},
  volume={29 5},
  pages={573-82}
}
To update oncologists on pathogenesis, contemporary diagnosis, risk stratification, and treatment strategies in BCR-ABL1-negative myeloproliferative neoplasms, including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Recent literature was reviewed and interpreted in the context of the authors' own experience and… CONTINUE READING